Graig Suvannavejh
Stock Analyst at Mizuho Securities
Total Price Targets
42
Stocks Covered
15
Sectors
Healthcare
Most Recent
Feb 19, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Graig Suvannavejh
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| INSM | Insmed Incorporated | $211.00 | $133.75 | +57.8% | 7 | Feb 19, 2026 |
| IMTX | Immatics N.V. | $25.00 | $10.82 | +131.1% | 3 | Feb 19, 2026 |
| IMMX | Immix Biopharma, Inc. | $14.00 | $9.35 | +49.7% | 1 | Feb 9, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $30.00 | $15.49 | +93.7% | 3 | Jan 29, 2026 |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $6.00 | $2.53 | +137.2% | 2 | Jan 5, 2026 |
| AXSM | Axsome Therapeutics, Inc. | $217.00 | $204.09 | +6.3% | 5 | Dec 31, 2025 |
| TERN | Terns Pharmaceuticals, Inc. | $33.00 | $52.94 | -37.7% | 3 | Nov 28, 2025 |
| APLS | Apellis Pharmaceuticals, Inc. | $19.00 | $40.95 | -53.6% | 4 | Nov 3, 2025 |
| EYPT | EyePoint Pharmaceuticals, Inc. | $33.00 | $13.33 | +147.6% | 3 | Oct 29, 2025 |
| VSTM | Verastem, Inc. | $14.00 | $5.86 | +138.9% | 2 | Oct 21, 2025 |
| HRMY | Harmony Biosciences Holdings, Inc. | $52.00 | $31.74 | +63.8% | 2 | Oct 10, 2024 |
| IDYA | IDEAYA Biosciences, Inc. | $55.00 | $28.27 | +94.6% | 2 | Sep 25, 2024 |
| BTAI | BioXcel Therapeutics, Inc. | $1.00 | $1.22 | -18.0% | 2 | Sep 23, 2024 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $3.00 | $16.04 | -81.3% | 2 | May 14, 2024 |
| IMRX | Immuneering Corporation | $8.00 | $5.39 | +48.4% | 1 | Apr 2, 2024 |
Recent Activity
- Feb 19, 2026— Set$25.00price target onIMTX(Immatics N.V.)
- Feb 19, 2026— Set$211.00price target onINSM(Insmed Incorporated)
- Feb 9, 2026— Set$14.00price target onIMMX(Immix Biopharma, Inc.)
- Jan 29, 2026— Set$30.00price target onCRVS(Corvus Pharmaceuticals, Inc.)
- Jan 5, 2026— Set$6.00price target onNMRA(Neumora Therapeutics, Inc. Common Stock)
- Dec 31, 2025— Set$217.00price target onAXSM(Axsome Therapeutics, Inc.)
- Dec 18, 2025— Set$212.00price target onINSM(Insmed Incorporated)
- Dec 1, 2025— Set$256.00price target onINSM(Insmed Incorporated)
- Nov 28, 2025— Set$33.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Nov 3, 2025— Set$19.00price target onAPLS(Apellis Pharmaceuticals, Inc.)
- Oct 29, 2025— Set$196.00price target onINSM(Insmed Incorporated)
- Oct 29, 2025— Set$33.00price target onEYPT(EyePoint Pharmaceuticals, Inc.)
- Oct 29, 2025— Set$19.00price target onIMTX(Immatics N.V.)
- Oct 22, 2025— Set$9.00price target onTERN(Terns Pharmaceuticals, Inc.)
- Oct 21, 2025— Set$14.00price target onVSTM(Verastem, Inc.)
- Oct 20, 2025— Set$28.00price target onEYPT(EyePoint Pharmaceuticals, Inc.)
- May 20, 2025— Set$11.00price target onCRVS(Corvus Pharmaceuticals, Inc.)
- Mar 27, 2025— Set$216.00price target onAXSM(Axsome Therapeutics, Inc.)
- Feb 3, 2025— Set$137.00price target onAXSM(Axsome Therapeutics, Inc.)
- Oct 22, 2024— Set$12.00price target onCRVS(Corvus Pharmaceuticals, Inc.)
Frequently Asked Questions
Who is Graig Suvannavejh?
Graig Suvannavejh is a stock analyst at Mizuho Securities covering 15 stocks primarily in Healthcare. They have issued 42 price targets since Aug 15, 2023.
What stocks does Graig Suvannavejh cover?
Graig Suvannavejh currently covers 15 stocks, including INSM, AXSM, APLS, IMTX, CRVS.
What is Graig Suvannavejh's latest price target?
Graig Suvannavejh's most recent price target was $25.00 on IMTX (Immatics N.V.), set on Feb 19, 2026.
What is Graig Suvannavejh's highest price target?
Graig Suvannavejh's highest issued price target is $256.00 on INSM, set on Dec 1, 2025.
More Analysts at Mizuho Securities
Coverage based on publicly published price targets. Not investment advice.